STERIS’ (TSE:STE – Free Report) – Equities researchers at Cormark increased their FY2025 earnings per share estimates for shares of STERIS’ in a note issued to investors on Thursday, March 13th. Cormark analyst B. Watson now expects that the company will post earnings of $0.52 per share for the year, up from their previous forecast of $0.38. Cormark has a “Moderate Buy” rating on the stock. Cormark also issued estimates for STERIS’’s FY2026 earnings at $0.61 EPS.
Separately, Atb Cap Markets upgraded STERIS’ to a “strong-buy” rating in a research note on Sunday, December 22nd.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
See Also
- Five stocks we like better than STERIS’
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Can TikTok Stock Picks Really Make You Rich?
- What Investors Need to Know to Beat the Market
- The “Quality” Rotation: Back to Basics Investing
- Profitably Trade Stocks at 52-Week Highs
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20240125142140&h=45&w=95&zc=2){kind=logo}
